-
-
-
-
-
-
-
Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
-
-
-
-
-
-
-
Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
10,128 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

